How to account for hallucinations in the interpretation of the antidepressant effects of psychedelics: a translational framework

RATIONALE: Recent trials with psychedelics in major depressive disorder and treatment-resistant depression showed remarkable improvements in depressive symptoms that can last for up to several months after even a single administration. The lack of an appropriate placebo control group—as patients are...

Descripción completa

Detalles Bibliográficos
Autores principales: van den Berg, Manon, Magaraggia, Igor, Schreiber, Rudy, Hillhouse, Todd M., Porter, Joseph H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Theoretical and Methodological Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166823/
https://www.ncbi.nlm.nih.gov/pubmed/35348806
http://dx.doi.org/10.1007/s00213-022-06106-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166823/
https://www.ncbi.nlm.nih.gov/pubmed/35348806
http://dx.doi.org/10.1007/s00213-022-06106-8

Ejemplares similares